Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Sept 2026 for Spyre Therapeutics, Inc., €1.4M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Scott Burrows: trading record in brief
This profile gathers the share dealings of Scott Burrows in Spyre Therapeutics, Inc. Over a trading history stretching from 25 June 2026 to 30 September 2026, the count stands at 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 30 September 2026 with a transaction (€1.4M) in Spyre Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Scott Burrows
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
17,500 shares@ US$89.8947CommonSEC144:0001950047-26-009876
30,000 shares@ US$98.330.039% mcap100.0% of flowCommonSEC144:0001950047-26-007571
15,000 shares@ US$87.1320.015% mcap100.0% of flowCommonSEC144:0001950047-26-006485
3 of 3 declarations
